SG10201608412SA - TABLET COMPRISING 7-[4-(4-BENZO[ b ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF - Google Patents
TABLET COMPRISING 7-[4-(4-BENZO[ b ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOFInfo
- Publication number
- SG10201608412SA SG10201608412SA SG10201608412SA SG10201608412SA SG10201608412SA SG 10201608412S A SG10201608412S A SG 10201608412SA SG 10201608412S A SG10201608412S A SG 10201608412SA SG 10201608412S A SG10201608412S A SG 10201608412SA SG 10201608412S A SG10201608412S A SG 10201608412SA
- Authority
- SG
- Singapore
- Prior art keywords
- quinolin
- thiophen
- piperazin
- benzo
- butoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011227057 | 2011-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201608412SA true SG10201608412SA (en) | 2016-12-29 |
Family
ID=48081918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2014013783A SG2014013783A (en) | 2011-10-14 | 2012-10-12 | TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR SALT THEREOF |
| SG10201608412SA SG10201608412SA (en) | 2011-10-14 | 2012-10-12 | TABLET COMPRISING 7-[4-(4-BENZO[ b ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2014013783A SG2014013783A (en) | 2011-10-14 | 2012-10-12 | TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR SALT THEREOF |
Country Status (32)
| Country | Link |
|---|---|
| US (7) | US20140234417A1 (en) |
| EP (1) | EP2767285B1 (en) |
| JP (2) | JP6084161B2 (en) |
| KR (1) | KR102072371B1 (en) |
| CN (2) | CN107397730A (en) |
| AP (1) | AP2014007564A0 (en) |
| AR (1) | AR088319A1 (en) |
| AU (1) | AU2012321723C1 (en) |
| BR (1) | BR112014008603A2 (en) |
| CA (1) | CA2851588C (en) |
| CL (1) | CL2014000909A1 (en) |
| CO (1) | CO6950480A2 (en) |
| CY (1) | CY1122460T1 (en) |
| DK (1) | DK2767285T3 (en) |
| EA (1) | EA032930B1 (en) |
| ES (1) | ES2762479T3 (en) |
| HR (1) | HRP20200037T1 (en) |
| HU (1) | HUE047493T2 (en) |
| IL (1) | IL231513B (en) |
| IN (1) | IN2014DN02055A (en) |
| JO (1) | JO3753B1 (en) |
| LT (1) | LT2767285T (en) |
| MX (1) | MX2014004135A (en) |
| MY (1) | MY173370A (en) |
| PL (1) | PL2767285T3 (en) |
| PT (1) | PT2767285T (en) |
| SG (2) | SG2014013783A (en) |
| SI (1) | SI2767285T1 (en) |
| TW (1) | TWI634908B (en) |
| UA (1) | UA114411C2 (en) |
| WO (1) | WO2013054872A1 (en) |
| ZA (1) | ZA201402333B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JO3753B1 (en) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof |
| JOP20200109A1 (en) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | Injectable preparation |
| JP5936732B1 (en) * | 2015-03-05 | 2016-06-22 | 日本カラコン合同会社 | Film coating composition |
| CN105106142B (en) * | 2015-09-22 | 2018-05-22 | 成都欣捷高新技术开发有限公司 | It is a kind of containing according to lyophilized oral formulations of piperazine azoles and preparation method thereof |
| CN106994119A (en) * | 2016-01-22 | 2017-08-01 | 浙江华海药业股份有限公司 | Contain oral disnitegration tablet according to a piperazine azoles or its salt and preparation method thereof |
| AU2017220971A1 (en) * | 2016-02-19 | 2018-08-02 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof |
| US20190201345A1 (en) * | 2016-06-28 | 2019-07-04 | Japan Antivirus Res. Inst., Ltd. | Excipient and tablet |
| CN109475557B (en) * | 2016-07-27 | 2022-01-07 | 日本脏器制药株式会社 | Film-coated tablet containing methotrexate |
| WO2018033483A1 (en) | 2016-08-16 | 2018-02-22 | H E X A L Aktiengesellschaft | Pharmaceutical compositions of a benzothiophene compound |
| EP3500247B1 (en) | 2016-08-16 | 2020-05-27 | H e x a l Aktiengesellschaft | Immediate release tablet of a benzothiophene compound |
| CN106496206A (en) * | 2016-08-31 | 2017-03-15 | 安徽省润生医药股份有限公司 | A kind of according to a new preparation method of piperazine azoles |
| EP3585392A1 (en) * | 2017-02-23 | 2020-01-01 | Boehringer Ingelheim International GmbH | New medical use of compound iii |
| JP7166754B2 (en) * | 2017-11-22 | 2022-11-08 | 沢井製薬株式会社 | Formulations containing dasatinib anhydrate |
| EP3501506B1 (en) | 2017-12-19 | 2019-10-09 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising brexpiprazole |
| EP3545950A1 (en) | 2018-03-26 | 2019-10-02 | Adamed sp. z o.o. | Pharmaceutical composition comprising brexpiprazole |
| JPWO2021029020A1 (en) * | 2019-08-13 | 2021-02-18 | ||
| CN112168794A (en) * | 2020-10-27 | 2021-01-05 | 浙江诺得药业有限公司 | Preparation method of brexpiprazole tablets |
| TWI820674B (en) * | 2021-04-13 | 2023-11-01 | 大陸商上海雲晟研新生物科技有限公司 | Brexpiprazole oral film, manufacture method thereof, and use thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562375B1 (en) * | 1999-08-04 | 2003-05-13 | Yamanouchi Pharmaceuticals, Co., Ltd. | Stable pharmaceutical composition for oral use |
| AU2002353659A1 (en) * | 2001-12-18 | 2003-07-15 | Synthon B.V. | Simvastatin dosage forms |
| JP4584706B2 (en) * | 2002-05-03 | 2010-11-24 | イスラエル インスティチュート フォー バイオロジカル リサーチ | Methods and compositions for treating central and peripheral nervous system disorders, and novel compounds useful therefor |
| EA008596B1 (en) | 2003-04-29 | 2007-06-29 | Пфайзер Инк. | 5,7-DIAMINOPYRAZOLO[4,3-d]PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION |
| KR20060081656A (en) * | 2003-06-09 | 2006-07-13 | 다우 글로벌 테크놀로지스 인크. | Stabilized organoborane polymerization initiators and polymerizable compositions |
| JP2006061067A (en) * | 2004-08-26 | 2006-03-09 | Asahi Kasei Life & Living Corp | Oxygen indicator |
| GB0504203D0 (en) * | 2005-03-01 | 2005-04-06 | Novartis Ag | Organic compounds |
| ES2526415T3 (en) | 2005-03-17 | 2015-01-12 | Synthon B.V. | Pharmaceutical tablets of crystalline aripiprazole type II |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP4315393B2 (en) | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | Heterocyclic compounds |
| US8865722B2 (en) | 2006-01-05 | 2014-10-21 | Teva Pharmaceutical Industries Ltd. | Wet formulations of aripiprazole |
| JP4806595B2 (en) * | 2006-07-05 | 2011-11-02 | 富士フイルム株式会社 | Solid-state image sensor driving device and digital camera |
| JP4540700B2 (en) * | 2006-10-13 | 2010-09-08 | 大塚製薬株式会社 | Medicine |
| EP2132173B1 (en) * | 2007-02-26 | 2015-10-07 | Merck Sharp & Dohme Corp. | Formulations for cathepsin k inhibitors |
| JP5432720B2 (en) * | 2007-03-13 | 2014-03-05 | 武田薬品工業株式会社 | 2-[[6-[(3R) -3-Amino-1-piperidinyl] -3,4-dihydro-3-methyl-2,4-dioxo-1 (2H) -pyrimidinyl] methyl] -4-fluorobenzo Solid formulation containing nitrile |
| KR20100016270A (en) * | 2007-05-11 | 2010-02-12 | 산텐 세이야꾸 가부시키가이샤 | Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
| MX2010003989A (en) | 2007-10-12 | 2010-04-27 | Astrazeneca Ab | Composition 064. |
| JP5463564B2 (en) * | 2009-05-22 | 2014-04-09 | 国立大学法人信州大学 | Heat and salt resistant cellulase preparations |
| TR201000948A1 (en) | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazole formulations. |
| TWI636784B (en) * | 2011-04-05 | 2018-10-01 | 大塚製藥股份有限公司 | PHARMACEUTICAL COMPOSITION AND KIT COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE AND USE THEREOF |
| US9839684B2 (en) | 2011-04-06 | 2017-12-12 | Biovaxim Limited | Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance |
| JO3753B1 (en) * | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof |
-
2012
- 2012-10-04 JO JOP/2012/0301A patent/JO3753B1/en active
- 2012-10-09 TW TW101137267A patent/TWI634908B/en active
- 2012-10-12 KR KR1020147010656A patent/KR102072371B1/en active IP Right Grant
- 2012-10-12 BR BR112014008603A patent/BR112014008603A2/en not_active Application Discontinuation
- 2012-10-12 EA EA201490783A patent/EA032930B1/en active Protection Beyond IP Right Term
- 2012-10-12 SG SG2014013783A patent/SG2014013783A/en unknown
- 2012-10-12 WO PCT/JP2012/076415 patent/WO2013054872A1/en active Application Filing
- 2012-10-12 SI SI201231718T patent/SI2767285T1/en unknown
- 2012-10-12 CA CA2851588A patent/CA2851588C/en active Active
- 2012-10-12 PL PL12840025T patent/PL2767285T3/en unknown
- 2012-10-12 AR ARP120103801A patent/AR088319A1/en not_active Application Discontinuation
- 2012-10-12 AU AU2012321723A patent/AU2012321723C1/en active Active
- 2012-10-12 CN CN201710266863.7A patent/CN107397730A/en active Pending
- 2012-10-12 JP JP2013538582A patent/JP6084161B2/en active Active
- 2012-10-12 MY MYPI2014700632A patent/MY173370A/en unknown
- 2012-10-12 SG SG10201608412SA patent/SG10201608412SA/en unknown
- 2012-10-12 HU HUE12840025A patent/HUE047493T2/en unknown
- 2012-10-12 LT LTEP12840025.6T patent/LT2767285T/en unknown
- 2012-10-12 PT PT128400256T patent/PT2767285T/en unknown
- 2012-10-12 ES ES12840025T patent/ES2762479T3/en active Active
- 2012-10-12 UA UAA201405029A patent/UA114411C2/en unknown
- 2012-10-12 DK DK12840025.6T patent/DK2767285T3/en active
- 2012-10-12 CN CN201280050586.1A patent/CN103889425B/en active Active
- 2012-10-12 US US14/351,325 patent/US20140234417A1/en not_active Abandoned
- 2012-10-12 AP AP2014007564A patent/AP2014007564A0/en unknown
- 2012-10-12 EP EP12840025.6A patent/EP2767285B1/en active Active
- 2012-10-12 MX MX2014004135A patent/MX2014004135A/en active IP Right Grant
-
2014
- 2014-03-13 IL IL231513A patent/IL231513B/en active IP Right Grant
- 2014-03-19 IN IN2055DEN2014 patent/IN2014DN02055A/en unknown
- 2014-03-28 ZA ZA2014/02333A patent/ZA201402333B/en unknown
- 2014-04-10 CL CL2014000909A patent/CL2014000909A1/en unknown
- 2014-05-07 CO CO14098041A patent/CO6950480A2/en unknown
-
2016
- 2016-02-09 US US15/019,874 patent/US20160158227A1/en not_active Abandoned
-
2017
- 2017-01-20 JP JP2017008854A patent/JP2017088610A/en active Pending
- 2017-02-27 US US15/444,113 patent/US20170165258A1/en not_active Abandoned
- 2017-09-22 US US15/713,427 patent/US10307419B2/en active Active
-
2019
- 2019-04-12 US US16/383,488 patent/US20190240215A1/en not_active Abandoned
-
2020
- 2020-01-08 CY CY20201100009T patent/CY1122460T1/en unknown
- 2020-01-09 HR HRP20200037TT patent/HRP20200037T1/en unknown
- 2020-10-01 US US17/061,394 patent/US20210023078A1/en not_active Abandoned
-
2022
- 2022-03-07 US US17/653,838 patent/US20220331311A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201608412SA (en) | TABLET COMPRISING 7-[4-(4-BENZO[ b ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF | |
| EP2742497A4 (en) | Proximity tag | |
| IL229963A0 (en) | Substituted quinolines and their use as medicaments | |
| GB201113478D0 (en) | Sensing systems | |
| EP2678090A4 (en) | Extended area filter | |
| EP2749066A4 (en) | Processing state information | |
| EP2653006A4 (en) | Wireless sensor network information swarming | |
| LU91843B1 (en) | Plural-frequency capacitive occupancy sensing system | |
| GB201506841D0 (en) | A centralisation system | |
| HK1205514A1 (en) | Antibacterial quinoline derivatives | |
| HK1199250A1 (en) | Biaryl heterocycle substituted oxazolidinon antibacterial drug | |
| EP2692158A4 (en) | Publishing location information | |
| GB201108356D0 (en) | Event identification | |
| PL2575503T3 (en) | Product comprising catechins | |
| GB201206384D0 (en) | Antibacterial drug derivatives | |
| HK1201520A1 (en) | Antibacterial quinoline derivatives | |
| GB201219102D0 (en) | In-memory continuous data protection | |
| HUE047982T2 (en) | Vitrified sintered product | |
| GB2492816B (en) | Medicines spoon | |
| AU338686S (en) | Cardigan | |
| AU338175S (en) | Cardigan | |
| AU337630S (en) | Cardigan | |
| GB201108458D0 (en) | Card protector | |
| GB201206386D0 (en) | Antibacterial drug derivaties | |
| GB201204738D0 (en) | New spoon |